Lactate Kinetics in veterinary Critical Care: A Review

Elevation in blood lactate concentration, with or without accompanying metabolic acidosis, is a hallmark finding in patients with circulatory compromise, and is also consistently noted in other conditions affecting critically ill or injured individuals. Little is reported in a veterinary literature regarding lactate measurement in the emergency and critical care setting, despite impressive reports of the clinical usefulness of lactate measurement in people. The purpose of this article is to review lactate kinetics and the clinical utility of lactate measurement. Limitations to lactate evaluation will also be discussed.     

Relationship of plasma lactate production to cortisol release following completion of different types of sporting events in horses

Fifty-eight healthy horses were studied during five sporting events of various intensities and durations, namely show-jumping (n=6), cross-country in a three-day event (n=30), trotting races (n=7), galloping reces (n=7) and endurance rides (n=8). Venous blood samples were collected at rest and immediately after exercise and analysed for plasma cortisol (CORT) and lactate (LA) levels. The experimental procedure was the same throughout the investigation so as to permit a reliable comparison between the five types of exercise. The type of event significantly affected both the resting (p0.05) and the postexercise (p0.01) plasma CORT. The degree of exercise-induced hypercortisolaemia was related to both the intensity and the duration of exercise for all five sporting events, but the endurance ride induced the most and show-jumping the least serious post-exercise CORT changes. LA production was much more closely related to the intensity of the exercise than was CORT. It is concluded that simultaneous measurements of plasma CORT and LA levels may be useful to discriminate between different types of exercise, adjust training programmes, and improve our comprehension of the physiology of sport horses at exercise.Abbreviations CORT cortisol - E/R exercise to rest ratio - EDTA ethylenediaminetetraacetic acid - HR heart rate - LA lactate     

瘤胃上皮内的乳酸吸收及其转运载体蛋白研究进展

乳酸作为瘤胃内的中间代谢产物,其合理的清除与有效的利用在由高精料诱导的瘤胃酸中毒的研究中十分重要。现有研究表明,瘤胃上皮在乳酸吸收方面发挥着一定的作用,因此,本文从瘤胃上皮的乳酸吸收以及吸收过程中涉及的转运载体蛋白进行综述,为进一步了解乳酸在瘤胃内的转运过程提供理论依据。     

饲粮添加硬脂酰乳酸钠对断奶仔猪生长性能、血清生化指标及养分表观消化率的影响

本试验旨在研究硬脂酰乳酸钠(SSL)对断奶仔猪生长性能、血清生化指标及养分表观消化率的影响。试验选择25日龄的断奶仔猪336头,按体重随机分为6组,每组7个重复,每个重复8头猪。各组仔猪饲粮中SSL添加水平分别为0(对照)、250、500、750、1 000和2 000 mg/kg,试验分2个阶段,每阶段21 d。试验测定仔猪生长性能,谷丙转氨酶、谷草转氨酶、总胆固醇等血清生化指标及能量、干物质、氮和粗脂肪表观消化率。结果表明:与对照组相比,1)饲粮中添加500、750和1 000 mg/kg SSL能显著降低仔猪第2阶段料重比(P0.05),添加1000 mg/kg SSL显著降低全期料重比(P0.05);2)饲粮中添加SSL有降低试验第42天仔猪血清谷草转氨酶、谷丙转氨酶活性,增加血清高密度蛋白胆固醇含量及高密度蛋白胆固醇/低密度蛋白胆固醇值的趋势,且当添加水平为2 000 mg/kg时差异达到显著水平(P0.05);3)饲粮中添加SSL能显著提高粗脂肪表观消化率(P0.05),并且有提高氮及能量表观消化率的趋势,当添加水平为2 000 mg/kg时差异达到显著水平(P0.05)。结果提示,饲粮添加SSL能降低仔猪料重比,提高饲料养分尤其是粗脂肪的表观消化率。     

乳酸锌对断奶肉兔生长性能、肠道发育和血清生化指标的影响

本试验旨在研究饲粮中添加乳酸锌对断奶肉兔生长性能、肠道发育和血清生化指标的影响。选择28日龄同期断奶新西兰兔420只,随机分为5组:对照组(饲喂基础饲粮,饲粮中添加硫酸锌形式的锌0 mg/kg)、硫酸锌组(在基础饲粮中添加硫酸锌形式的锌80 mg/kg)以及3个乳酸锌组(在基础饲粮中分别添加乳酸锌形式的锌20、40、80 mg/kg),每组14个重复,每个重复6只(公母各占1/2)。预试期7 d,正试期42 d。结果表明:1)与对照组相比,饲粮中添加40和80 mg/kg乳酸锌可以显著提高断奶肉兔的试验末重和平均日增重(P<0.05),显著降低料重比、腹泻率和死亡率(P<0.05),但对平均日采食量无显著影响(P>0.05);40 mg/kg乳酸锌组肉兔的试验末重、平均日增重和料重比与硫酸锌组差异不显著(P>0.05),但腹泻率和死亡率较低。2)与对照组相比,饲粮中添加40和80 mg/kg乳酸锌可以显著提高断奶肉兔小肠绒毛高度和绒毛高度/隐窝深度(P<0.05),显著降低十二指肠隐窝深度(P<0.05);80 mg/kg乳酸锌组肉兔十二指肠绒毛高度显著高于同水平硫酸锌组(P<0.05)。3)与对照组相比,饲粮中添加40和80 mg/kg乳酸锌可以显著提高断奶肉兔血清抗氧化酶活性及生长激素和胰岛素样生长因子-Ⅰ含量(P<0.05);40 mg/kg乳酸锌组肉兔血清生化指标与硫酸锌组差异不显著(P>0.05),80 mg/kg乳酸锌组在提高肉兔血清铜锌超氧化物歧化酶活性和生长激素含量方面优于同水平硫酸锌组。综上所述,饲粮中添加乳酸锌可以促进肉兔生长、降低腹泻率和死亡率、改善血清生化指标和肠道发育;乳酸锌的添加效果显著优于相同水平的硫酸锌,养兔生产中乳酸锌适宜添加水平为40 mg/kg。     

恩诺沙星与磺胺二甲嘧啶联合毒性探究

本研究旨在探究恩诺沙星与磺胺二甲嘧啶的联合毒性。选取SD大鼠为试验对象,将其分成6组,每组12只,分别为高剂量联合用药组（500 mg/kg体重）、中剂量联合用药组（250 mg/kg体重）、低剂量联合用药组（50 mg/kg体重）、恩诺沙星单药组（250 mg/kg体重）、磺胺二甲嘧啶单药组（250 mg/kg体重）及对照组（等量0.5%羧甲基纤维素钠溶液）,配制相应的药物进行灌胃,最后一次给药1 d后对大鼠进行称重、麻醉、心脏采血并剖检取肝脏组织,然后对大鼠增重率、血常规指标、血清生化指标及肝脏病理学变化几个方面进行分析,并利用SPSS 22.0软件评估2种药物的联合作用效果。结果显示,在雌性大鼠中,高、中剂量联合用药组使大鼠增重率显著下降（P<0.05）,雄性大鼠增重率无显著变化（P>0.05）;雄性大鼠给药组白细胞数量均显著增加（P<0.05）,高剂量联合用药组中性粒细胞和淋巴细胞占比分别表现为显著升高及下降（P<0.05）;高、中剂量联合用药组大鼠外周血中谷草转氨酶含量显著增加（P<0.05）,且高、中剂量联合用药组肝脏病理切片视野可见不同程度的炎性细胞浸润,并伴有不同程度的损伤。本研究结果表明,恩诺沙星和磺胺二甲嘧啶联用可使毒性增加,对大鼠的免疫系统状态有一定的影响,且能造成一定程度的肝脏损伤,剂量越高影响越大。本研究为恩诺沙星和磺胺二甲嘧啶联合用药机制的研究提供数据支持,并为二者的临床应用提供参考,提示新的食品安全评估应考虑药物联合暴露带来的影响。     

Relationship between Olsen P and Ammonium Lactate–Extractable P in Portuguese Acid Soils

The soil phosphorus (P) test in Portugal is based on extraction with ammonium lactate (AL) at acidic pH. Because this test is rarely used in other countries, it is desirable to see whether the AL-P values correlate with the more commonly used P tests. In this work, we compared AL-P with bicarbonate-extractable P (Olsen's method) for a group of 48 samples from Portuguese acidic soils differing widely in P status. Despite their contrasting composition, both reagents extracted phosphate from the same sources, albeit in different proportions. Both Olsen P and AL-P were strongly correlated with resin-extractable and dilute electrolyte-desorbable P, which are respectively related to the soil contents in phytoavailable P and P that can be released to runoff or drainage water. Olsen P and AL-P were strongly correlated (R² = 0.870), the correlation became stronger when three overfertilized soils were excluded (Olsen P = 2.35 + 0.45 AL-P; R² = 0.908; P ≤ 0.001, n = 45). No correlation was observed for a group of soils recently fertilized with Gafsa phosphate probably because the acidic AL reagent dissolved residual calcium phosphate, thus overestimating the soil content in desorbable P. On the basis of the present results and the AL-P-based fertility classes used for fertilizer recommendation purposes, Olsen P–based fertility classes were tentatively proposed for Portuguese acidic soils.     

Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin after Intramuscular Administration of Enrofloxacin in Goats

The pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin were investigated in goats after a single intramuscular administration of enrofloxacin at 2.5 mg/kg body weight. The plasma concentrations of enrofloxacin and ciprofloxacin were determined simultaneously by a HPLC method. The peak concentrations (C _max) of enrofloxacin (1.13 g/ml) and ciprofloxacin (0.24 g/ml) were observed at 0.8 and 1.2 h, respectively. The elimination half-life (t _1/2), volume of distribution (V _d(area)), total body clearance (Cl_B) and mean residence time (MRT) of enrofloxacin were 0.74 h, 1.42 L/kg, 1329 ml/h per kg and 1.54 h, respectively. The t _1/2, area under the plasma concentration–time curve (AUC) and the MRT of ciprofloxacin were 1.38 h, 0.74 g h/ml and 2.73 h, respectively. The metabolic conversion of enrofloxacin to ciprofloxacin was appreciable (36%) and the sum of the plasma concentrations of enrofloxacin and ciprofloxacin was maintained at or above 0.1 g/ml for up to 4 h. Enrofloxacin appears to be useful for the treatment of goat diseases associated with pathogens sensitive to this drug.     

恩诺沙星在猪组织中残留消除规律研究

在常规饲养条件下,对健康猪按2.5 mg/kg体重的剂量肌肉注射2.5%恩诺沙星注射液,每日2次,连续注射3 d.停药后第2、4、6、8、10、12、14天分别屠宰4头猪.分别采取每头猪的肌肉(注射部位)、脂肪(腹脂)、肝和肾脏等4种组织,用高效液相色谱法进行残留量测定.结果表明:残留在肌肉、脂肪组织中的药物消除较快,第8天总残留量(恩诺沙星 环丙沙星)已下降至检测限(20μg/kg)以下;肝和肾脏组织中的药物消除缓慢,第14天测得猪肾中药物总残留量为40μg/kg.